Type 2 Diabetes

Type 2 diabetes is a long-term condition in which the body either resists the effect of insulin or doesn't make enough of it, so glucose (sugar) builds up in the blood instead of fueling cells. It is the most common form of diabetes, develops gradually over years, and — caught early — can often be slowed, well-controlled, and in some cases pushed into remission.

What is type 2 diabetes?

Insulin is a hormone made by the pancreas that acts like a key, letting glucose move out of the bloodstream and into cells to be used for energy or stored. In type 2 diabetes, two problems usually occur together: the body's cells stop responding normally to insulin (insulin resistance), and over time the pancreas can no longer produce enough insulin to overcome that resistance (beta-cell dysfunction). The result is chronically elevated blood glucose, known as hyperglycemia (NIH; StatPearls).

This is different from type 1 diabetes, an autoimmune disease in which the immune system destroys the insulin-producing cells and the body makes little or no insulin at all. Type 2 accounts for the large majority of diabetes cases — roughly 90–95% — and is strongly linked to body weight, activity, genetics, and age, though it can occur in people of any size (CDC; ADA).

Type 2 diabetes is also a progressive condition that often begins silently. For years beforehand, many people pass through prediabetes, a stage where blood sugar is higher than normal but not yet in the diabetic range. According to the CDC, the great majority of people with prediabetes don't know they have it, which is why screening matters so much.

In medical records, type 2 diabetes is coded under ICD-10 E11, with additional digits specifying complications (for example, E11.9 for type 2 diabetes without complications, or E11.65 with hyperglycemia). Prediabetes is coded as R73.03.

What causes type 2 diabetes, and who is at risk?

Type 2 diabetes develops from a combination of genetic susceptibility and modifiable lifestyle and body-composition factors. The central mechanism most researchers emphasize is the accumulation of excess fat where it does not belong — particularly visceral fat around the abdominal organs and fat deposited inside the liver and muscle. This ectopic fat releases free fatty acids and inflammatory signals that interfere with insulin's action, driving the insulin resistance at the heart of the disease (StatPearls; NIH).

Major risk factors include:

• Overweight or obesity, especially central (abdominal) fat. This is the single strongest modifiable risk factor.
• Prediabetes. Up to a large fraction of people with prediabetes progress to type 2 diabetes over time, particularly without intervention (CDC).
• Physical inactivity. Muscle is the body's largest sink for glucose; sedentary muscle takes up far less.
• Family history of type 2 diabetes, reflecting a meaningful genetic component.
• Age 35 or older, though type 2 diabetes is increasingly diagnosed in younger adults and adolescents.
• Race and ethnicity — risk is higher among people of Black, Hispanic/Latino, Native American, Asian American, and Pacific Islander descent (CDC).
• History of gestational diabetes or delivering a baby weighing more than about 9 pounds.
• Polycystic ovary syndrome (PCOS), which is closely tied to insulin resistance (ACOG).
• High blood pressure, low HDL cholesterol, or high triglycerides — components of metabolic syndrome.
• Poor or insufficient sleep and obstructive sleep apnea, which worsen glucose handling.
• Certain medications, including some corticosteroids and antipsychotics.

The ADA recommends screening all adults beginning at age 35, and earlier in those who are overweight or obese and have one or more additional risk factors (ADA Standards of Care). Importantly, type 2 diabetes is not exclusive to people with obesity; lean individuals with significant insulin resistance can develop it too, often reflecting where fat is stored rather than total body weight.

What are the symptoms of type 2 diabetes?

Because blood sugar rises gradually, type 2 diabetes often produces few or no symptoms in its early stages, and many people are diagnosed through routine blood work before they ever feel unwell. When symptoms do appear, they tend to reflect elevated glucose and include:

• Increased thirst and a dry mouth
• Frequent urination, especially at night
• Increased hunger
• Unexplained fatigue
• Blurred vision
• Slow-healing cuts or sores, and frequent infections (skin, gum, urinary, or yeast infections)
• Tingling or numbness in the hands or feet (a sign of nerve involvement)
• Unintended weight loss in some cases

A more specific visible clue can be acanthosis nigricans — velvety, darkened patches of skin in the neck folds, armpits, or groin — which is linked to the high insulin levels of insulin resistance (StatPearls; AAD). Because symptoms are subtle and easy to dismiss, clinicians emphasize screening high-risk people rather than waiting for complaints.

How is type 2 diabetes diagnosed?

Diagnosis is based on blood tests that measure glucose, interpreted against thresholds set by the American Diabetes Association (ADA). Per the ADA Standards of Care in Diabetes, diabetes can be diagnosed by any of the following (ADA):

• HbA1c (A1C) of 6.5% or higher. A1C reflects average blood glucose over roughly the prior 2–3 months and does not require fasting.
• Fasting plasma glucose of 126 mg/dL (7.0 mmol/L) or higher after at least 8 hours without eating.
• 2-hour plasma glucose of 200 mg/dL (11.1 mmol/L) or higher during a 75-gram oral glucose tolerance test (OGTT).
• Random plasma glucose of 200 mg/dL (11.1 mmol/L) or higher in a person with classic symptoms of hyperglycemia.

In the absence of unequivocal hyperglycemia, a diagnosis generally requires two abnormal test results — either two of the same test on different days, or two different abnormal tests from the same sample (ADA).

Prediabetes is defined by intermediate values (ADA):

• A1C of 5.7%–6.4%
• Fasting glucose of 100–125 mg/dL (impaired fasting glucose)
• 2-hour OGTT glucose of 140–199 mg/dL (impaired glucose tolerance)

A1C offers practical advantages — no fasting required, greater stability, and less day-to-day variation from stress, illness, or recent meals — but it can be unreliable in certain conditions such as some anemias, hemoglobin variants, pregnancy, or recent blood loss, where glucose-based testing is preferred (ADA). After diagnosis, doctors typically also check kidney function, cholesterol, blood pressure, and perform eye and foot exams to screen for complications.

How is type 2 diabetes treated?

Treatment follows a clear hierarchy and is increasingly individualized. The goals are to bring blood glucose into a safe range, protect the heart and kidneys, manage related risk factors, and prevent complications. Many people use a combination of lifestyle change and one or more medications.

Lifestyle first — the foundation

Lifestyle modification is recommended for everyone with type 2 diabetes and is powerful on its own, especially early. The landmark Diabetes Prevention Program (DPP) showed that intensive lifestyle change — aiming for about 7% weight loss and 150 minutes of weekly activity — reduced progression from prediabetes to type 2 diabetes substantially, and outperformed medication (NIH; ADA). Core elements include:

• Weight management. Even a modest loss of around 5–7% of body weight meaningfully improves blood sugar; larger losses (10–15% or more) can put diabetes into remission for some people, particularly soon after diagnosis.
• Physical activity — roughly 150 minutes per week of moderate aerobic activity plus resistance/strength training. Contracting muscle takes up glucose even without insulin.
• Dietary pattern. No single "diabetes diet" exists, but evidence supports patterns rich in vegetables, legumes, whole grains, fiber, lean protein, and healthy fats (such as Mediterranean-style eating), while limiting sugar-sweetened beverages, refined carbohydrates, and ultra-processed foods (ADA).
• Stopping smoking, limiting alcohol, and improving sleep, all of which affect glucose control and cardiovascular risk.
• Blood glucose monitoring, which may include continuous glucose monitors (CGMs) for some people.

Over-the-counter measures

There is no OTC medication that treats type 2 diabetes, and supplements should not replace prescribed therapy. Useful OTC tools center on supporting lifestyle and monitoring: home glucose meters and test strips, well-fitting footwear and foot-care supplies (to prevent ulcers), and a daily low-dose aspirin only when specifically recommended by a clinician for cardiovascular protection. Some supplements (such as cinnamon, berberine, or chromium) are marketed for blood sugar, but the evidence is limited and inconsistent, and they can interact with medications — discuss any with a doctor before use.

Prescription medications

Several real drug classes are used, often in combination, and choice increasingly depends on a person's heart and kidney health rather than blood sugar alone (ADA Standards of Care):

• Metformin (a biguanide) has long been a foundational, low-cost first-line agent that lowers glucose production by the liver and improves insulin sensitivity.
• SGLT2 inhibitors (e.g., empagliflozin, dapagliflozin, canagliflozin) cause the kidneys to excrete excess glucose and have proven benefits for the heart and kidneys. ADA guidance recommends them — independent of A1C — for people with established cardiovascular disease, heart failure, or chronic kidney disease.
• GLP-1 receptor agonists (e.g., semaglutide, dulaglutide, liraglutide) and the dual GIP/GLP-1 agonist tirzepatide lower glucose, promote weight loss, and offer cardiovascular benefit; they are favored when weight loss or heart protection is a priority.
• DPP-4 inhibitors (e.g., sitagliptin, linagliptin), which modestly lower glucose with low risk of hypoglycemia.
• Sulfonylureas (e.g., glipizide, glimepiride), which stimulate insulin release; effective and inexpensive but can cause low blood sugar and weight gain.
• Thiazolidinediones / TZDs (e.g., pioglitazone), which improve insulin sensitivity.
• Insulin, used when other therapies are insufficient or blood sugar is very high; many people with type 2 diabetes eventually benefit from it.

Because the field is moving toward protecting organs, current ADA guidance emphasizes choosing agents like SGLT2 inhibitors and GLP-1 receptor agonists for people with heart or kidney disease, with or without metformin (ADA). All medication decisions should be individualized with a clinician.

Can type 2 diabetes be prevented or managed long-term?

For prevention, the evidence is strong and encouraging. In people with prediabetes, structured lifestyle programs — the basis of the CDC's National Diabetes Prevention Program — can substantially lower the risk of developing type 2 diabetes; in the DPP, lifestyle change reduced new cases more effectively than medication (CDC; NIH). Metformin is sometimes used preventively in higher-risk individuals.

For those already diagnosed, long-term management is about consistency and protecting against complications. That means keeping blood glucose, blood pressure, and cholesterol within target ranges; attending regular eye, kidney, and foot screenings; staying up to date on vaccinations; and addressing weight, activity, and smoking. The concept of diabetes remission — sustained normal blood sugar without glucose-lowering medication — is now recognized and is most achievable through significant weight loss, particularly within the first few years after diagnosis. Remission is not the same as cure; ongoing monitoring is still needed.

When should you see a doctor?

See a healthcare provider if you have risk factors and have not been screened, or if you notice symptoms such as increased thirst, frequent urination, persistent fatigue, blurred vision, slow-healing sores, or numbness and tingling in the hands or feet. People who already have diabetes should seek prompt care for foot wounds, infections, or blood sugar readings that are consistently outside their target range.

Certain symptoms are medical emergencies. Seek immediate care for signs of dangerously high blood sugar or its complications, including confusion, very rapid or deep breathing, fruity-smelling breath, severe abdominal pain, persistent vomiting, or extreme drowsiness. For people on insulin or sulfonylureas, severe low blood sugar (hypoglycemia) — with shakiness, sweating, confusion, or loss of consciousness — also requires urgent treatment.

What is the outlook (prognosis) for type 2 diabetes?

With modern care, the outlook for type 2 diabetes is generally good, and many people live long, full lives. Well-controlled blood sugar, blood pressure, and cholesterol dramatically lower the risk of the most serious complications, which include heart disease and stroke, kidney disease, nerve damage (neuropathy), vision loss (retinopathy), and foot problems that can lead to amputation (CDC; NIH).

Because type 2 diabetes is progressive, treatment often needs to evolve over time, and medication needs may increase. But the trajectory is far from fixed: early diagnosis, sustained lifestyle change, weight management, and newer medications with proven heart and kidney benefits have meaningfully improved long-term outcomes. The central message is one of agency — the daily choices and consistent monitoring that manage type 2 diabetes also protect the heart, kidneys, and overall longevity.

Frequently asked questions

Can type 2 diabetes be reversed or cured? There is no permanent cure, but type 2 diabetes can sometimes enter remission, meaning normal blood sugar without glucose-lowering medication. This is most achievable through substantial, sustained weight loss — especially within the first few years after diagnosis — and is more likely the earlier it is pursued. Remission still requires ongoing monitoring, because the condition can return.

What's the difference between type 1 and type 2 diabetes? Type 1 is an autoimmune disease in which the body destroys its insulin-producing cells and makes little or no insulin; it usually appears in childhood or young adulthood and always requires insulin. Type 2 involves insulin resistance plus a gradual decline in insulin production, develops mostly in adults (though increasingly in younger people), and is strongly tied to weight, activity, and genetics.

Is prediabetes the same as diabetes? No. Prediabetes means blood sugar is higher than normal but below the diabetic threshold (A1C 5.7–6.4%, or fasting glucose 100–125 mg/dL). It is a warning stage and a major risk factor for type 2 diabetes, but it is often reversible. Lifestyle change at this stage is highly effective at preventing progression (CDC; ADA).

Do I have to take insulin if I have type 2 diabetes? Not necessarily. Many people manage type 2 diabetes with lifestyle change and oral or non-insulin injectable medications. Insulin is added when other treatments aren't enough or blood sugar is very high. Needing insulin is not a personal failure — it reflects the progressive nature of the disease and the goal of keeping blood sugar safely controlled.

What A1C number means I have diabetes? An A1C of 6.5% or higher meets the diagnostic threshold for diabetes; 5.7%–6.4% indicates prediabetes; and below 5.7% is considered normal (ADA). Diagnosis usually requires a confirmatory test unless there are clear symptoms of high blood sugar. A1C can be misleading in some conditions, so doctors may rely on glucose-based tests instead.

*This page is for general education and is not medical advice. Talk to a qualified healthcare professional about diagnosis and treatment decisions specific to you.*